%0 Journal Article
%A López-Cano, Carolina
%A Ciudin, Andreea
%A Sánchez, Enric
%A Tinahones, Francisco J
%A Barbé, Ferran
%A Dalmases, Mireia
%A García-Ramírez, Marta
%A Soto, Alfonso
%A Gaeta, Anna Michela
%A Pellitero, Silvia
%A Martí, Raquel
%A Hernández, Cristina
%A Simó, Rafael
%A Lecube, Albert
%T Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.
%D 2022
%U http://hdl.handle.net/10668/20499
%X To evaluate the effect of liraglutide, a glucagon-like peptide 1 receptor agonist, on pulmonary function and serum levels of surfactant protein D (SP-D) in type 2 diabetes. A double-blind, randomized, crossover, placebo-controlled clinical trial comprising 76 patients with a baseline forced expiratory volume in 1 s
%~